NEWS

Pfizer CEO backtracks on jab effectiveness, admits two shots offer ‘very limited protection’

Updated: January 12, 2022 at 2:57 pm EST  See Comments

Wed Jan 12, 2022 – 1:45 pm EST

(LifeSiteNews) — The CEO of Pfizer has contradicted his prior claims that his company’s double-dose mRNA COVID-19 injections were “100% effective,” now stating that two doses of the jab don’t offer much protection against symptoms from the latest variant of COVID-19 “if any.” 

“We know that the two doses of the vaccine offer very limited protection, if any,” said Pfizer CEO and chairman Albert Bourla in a Monday interview with Yahoo! Finance.  

“The three doses with a booster, they offer reasonable protection against hospitalization and deaths – against deaths, I think, very good, and less protection against infection,” Bourla added. 

 

Pfizer CEO Bourla on Pfizer vaccine efficacy against #Omicron: “Two doses of the vaccine offers very limited protection, if any. 3 doses with a booster offer reasonable protection against hospitalization and deaths. Less protection against infection.” pic.twitter.com/wg9yho7Br5

— Sputnik V (@sputnikvaccine) January 11, 2022

The Pfizer boss had announced in April 2021 that the double-dose regimen of the jabs was 100% effective against severe COVID “as defined by the CDC,” and 95.3% effective against severe symptoms “as defined by the FDA.” 

 

The data also

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors

Advertisement
Hydro Flask Double Wall Vacuum Insulated Stainless Steel Bottle
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Official Street Preachers and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.